Dr. Jeffrey R. Jay, M.D.

Great Point Partners as of Sept. 30, 2015

Portfolio Holdings for Great Point Partners

Great Point Partners holds 35 positions in its portfolio as reported in the September 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Vanda Pharmaceuticals (VNDA) 7.7 $19M 1.7M 11.28
Five Prime Therapeutics 7.5 $19M 1.2M 15.39
Connecture 7.4 $19M 4.1M 4.56
Gw Pharmaceuticals Ads Call Option 7.4 $19M 204k 91.37
Adamas Pharmaceuticals 7.4 $19M 1.1M 16.74
Zogenix Com New 7.3 $18M 1.4M 13.50
Dyax 5.7 $14M 750k 19.09
Relypsa 5.6 $14M 769k 18.51
Exelixis (EXEL) 3.5 $8.9M 1.6M 5.61
Paratek Pharmaceuticals 3.4 $8.6M 454k 19.00
Tetraphase Pharmaceuticals 3.3 $8.4M 1.1M 7.46
Raptor Pharmaceutical 3.2 $8.1M 1.3M 6.05
Alcobra SHS 2.9 $7.3M 1.2M 6.04
Aradigm Corp Com No Par New 2.9 $7.2M 1.0M 7.20
Aurinia Pharmaceuticals (AUPH) 2.7 $6.9M 2.5M 2.82
Ocera Therapeutics 2.5 $6.2M 2.0M 3.16
Synergy Pharmaceuticals Del Com New 2.4 $6.0M 1.1M 5.30
Medicines Company 2.3 $5.7M 150k 37.96
Vericel (VCEL) 2.2 $5.7M 2.1M 2.71
Bovie Medical Corporation 2.1 $5.2M 2.7M 1.95
D Stemline Therapeutics 1.7 $4.2M 475k 8.83
Alimera Sciences 1.5 $3.7M 1.7M 2.21
Caladrius Biosciences 1.3 $3.4M 2.2M 1.49
Tenax Therapeutics 1.3 $3.3M 1.1M 3.00
Sunesis Pharmaceuticals Com New 1.0 $2.6M 3.3M 0.81
Antares Pharma 0.7 $1.7M 1.0M 1.70
Biodel Com New 0.6 $1.5M 3.3M 0.44
Aquinox Pharmaceuticals 0.6 $1.4M 100k 14.07
Osiris Therapeutics 0.5 $1.4M 75k 18.47
Flexion Therapeutics Call Option 0.4 $985k 66k 14.86
Transition Therapeutics Com New 0.3 $800k 447k 1.79
Discovery Laboratories Inc N Com New 0.3 $759k 2.5M 0.30
Threshold Pharmaceuticals Com New Call Option 0.3 $703k 211k 3.33
Derma Sciences 0.2 $477k 101k 4.71
Streamline Health Solutions (STRM) 0.1 $347k 152k 2.29